Regenerative Medicines Funding Supports BIGT Goals

The BioIndustry Association (BIA) has welcomed Lord Mandelson’s announcement that the Engineering and Physical Sciences Research Council (EPSRC) will invest £5.3 million over the next five years in a Centre for
Innovative Manufacturing in Regenerative Medicine at Loughborough University. The centre will also receive £3 million from 28 industrial and government partners. The Bioscience Innovation and Growth Team Review and Refresh of Bioscience 2015, published in January 2009, called for investment in the emerging regenerative medicine industry, which offers the possibility of cures, rather than life-long treatments. The Government’s New Industry New Jobs proposals and the Office for Life Sciences’ Life Sciences Blueprint also recognised that high technology manufacturing, such as that required in the regenerative medicines field, will be crucial to the UK’s economic future. Clive Dix, BIA Chairman, said: “This announcement about investment in regenerative medicine further exhibits the Government’s commitment to ensuring that the cutting edge science coming from the UK’s
innovative life sciences sector is turned into the world-leading treatments of the future.”